Unibest
← Back to patent-cliff list

Bulaquine

Tier C — Watch / trade

Bulaquine

Piramal
Originator
2000
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type

Targets:Not applicable

Brand:Aablaquin

Indications (approved):Plasmodium infection

Regional status

US
-
EU
-
China
-
Japan
-

Synthetic routes & intermediates1 routes

Originator routes × 0Optimised (non-patent) × 1Process routes × 0

Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

OptimisedRoute 1Steps 1 · Total yield 0.89 g (Bulaquine)
BULA-00190-34-6BULA-002517-23-7API · Bulaquine
CodeCAS No.Intermediate
BULA-00190-34-6N4-(6-methoxyquinolin-8-yl)pentane-1,4-diamine
BULA-002517-23-73-acetyldihydrofuran-2(3H)-one

Frequently asked questions

What are the approved indications of Bulaquine?

Approved indications include: Plasmodium infection.

When does the Bulaquine patent expire?

No public expiry year is available for Bulaquine yet; this page updates once verified.

How many synthesis routes are recorded for Bulaquine?

1 synthesis routes are recorded; the shortest is 1 steps with 0.89 g (Bulaquine) total yield. Intermediates in each route carry codes and CAS numbers.

Where can I buy Bulaquine intermediates?

All intermediates in Bulaquine routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.

How do I get a quote for Bulaquine intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-09-29